Research summary
Chronic obstructive pulmonary disease (COPD) causes breathing difficulties due to inflammation and damage in the lungs, often as a result of smoking or environmental exposures. Despite presenting a major global health challenge, COPD is underdiagnosed. Dr. Miranda Kirby, Canada Research Chair in Quantitative Imaging, is transforming how advanced imaging techniques are used to detect, monitor and manage COPD and other lung diseases.
Kirby has already developed innovative CT- and MRI-based biomarkers and machine learning models to improve early detection and risk prediction for lung disease. Now, she and her research team are developing new imaging techniques that extend beyond the lungs. They are also translating CT-based methods to MRI, which will make lung imaging safer because it does not use ionizing radiation. By improving COPD diagnosis and adapting these tools for other lung conditions, Kirby’s research will lead to better outcomes for patients and reduced health care costs.